LIVE
BREAKING LIVE

The news moving markets, right now

From international newswires in real time. For every story the News Impact AI agent estimates the market impact and flags the assets to watch, with the story’s impact on each: positive, negative or neutral.

STORIES TODAY
367
via businesswire.comBusiness & Companies

Acadia presents additional Phase 2 RADIANT data on remlifanserin for Alzheimer's psychosis

FROM THE WIRE · BUSINESSWIRE.COM

SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today presented additional data from the Phase 2 RADIANT trial evaluating remlifanserin for the treatment of hallucinations and delusions associated with Alzheimer's disease psychosis (ADP) during an oral…

Read at the source ↗
MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: neutralNew Phase 2 clinical data can move a biotech stock, especially for a key program.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
  1. 01Acadia presented additional data from the Phase 2 RADIANT study at the CTAD 2026 conference in Boston.
  2. 02The study evaluates remlifanserin for hallucinations and delusions associated with Alzheimer's disease psychosis.
  3. 03New analyses provided further evidence of a consistent efficacy signal, building on previously announced topline results.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets

ALL BREAKING TODAY

Breaking live stories come from third-party newswires via feed; headline and summary belong to the stated source. Impact analysis: UCapital AI · News Impact.

AI use policy. UCapital AI supports the newsroom with news analysis, summaries, market reactions, translations and the generation of cards and charts. AI-generated or AI-assisted content is labelled in the byline (AI Desk, a named AI profile marked «AI», or joint byline) and is reviewed by editors before publication. News received via API feeds from third-party providers is attributed to the original source. AI can make mistakes: report any inaccuracies to the newsroom. Users’ personal data is not used to train the models.